.jpg)
Global AI spending is expected to reach $2.59 trillion in 2026, according to Gartner. Most of that money will be approved by finance leaders who have no reliable way to tell a good AI investment from a mediocre one until well after the check clears.
That’s not a knock on CFOs. It’s a knock on what technology teams bring into the room. Model accuracy, deployment timelines, productivity forecasts — none of it answers the question that actually matters: will this change our competitive position, or just our operating costs for a quarter?
Skip that question, and the budget cycle turns into a rubber stamp.
The Metrics on the Table Aren’t the Metrics That Matter
A model that’s 94% accurate and a model that’s 87% accurate can produce wildly different business outcomes depending on what they’re attached to. Accuracy tells you the model works. It tells you nothing about whether the capability is rare, defensible, or worth building versus buying.
Here’s what that looks like in practice: a mid-market insurer we worked with had two AI initiatives up for the same budget cycle. One was a claims-summarization tool built on an off-the-shelf LLM wrapper — fast to ship, decent accuracy, and something every competitor could stand up in a quarter. The other was a underwriting-risk model trained on the company’s own 15 years of claims and loss data — slower to build, harder to explain in a slide, and not something a competitor could replicate without the same data history.
On a technology scorecard, the first project looked better: faster, cheaper, higher accuracy score. On a competitive scorecard, it was table stakes. The second was the one worth protecting.
When finance can’t see that distinction, both projects get funded at similar levels
and the company spends real money buying itself a tie with everyone else.
Funding Everything Equally Is Its Own Failure Mode
Equal funding feels fair. It isn’t neutral — it’s a decision, and usually the wrong one.
Some AI capabilities become commodity fast. Chatbots, document summarization, basic copilots — useful, but available to any competitor with a procurement budget and a few weeks. Money poured here buys parity, not advantage.
The initiatives worth real investment are the ones that:-
- Change the underlying cost structure of delivering the product or service, not just the cost of one team’s workflow
- Draw on data, process knowledge, or domain depth a competitor can’t easily assemble
- Have a named owner accountable for the business outcome, not just the technical delivery
Skip that filter and there’s a second cost that shows up later: when nobody owns the ROI, nobody can defend the budget in the next review. Scrutiny goes up across the board, and strong proposals start getting treated like weak ones just because the last cycle couldn’t produce a straight answer on what actually paid off.
Three Questions Before Money Moves
Not a scorecard. Not a framework with twelve boxes. Three questions, asked before approval, not after:
- Does it reduce the real cost of delivering the product or service — not the cost of a single team’s workflow?
- Does it create something competitors can’t easily copy — through data, process, or domain depth?
- Who owns the ROI, by name, with their performance tied to the outcome?
A “no” on question two doesn’t kill the project. It reclassifies it. That claims-summarization tool from the insurer example above was still worth doing — just not as a strategic bet. It went through as a cost-of-doing-business efficiency play with a much smaller budget, and nobody had to pretend it was something it wasn’t.
That reclassification is the actual value of the exercise. It’s not about saying no to more AI spending. It’s about being honest with yourself, in the room, before the money moves, instead of during next year’s budget review when someone finally asks what the last round of spending actually bought.
What This Looks Like Run Properly
This is the logic behind Parkar’s AI Readiness Diagnostic — a five-day, fixed-fee assessment that puts finance and business leaders in the room together to evaluate AI initiatives against business impact, not technology roadmaps.
It doesn’t produce a tool list. It produces a prioritized investment roadmap, with expected outcomes and a named owner attached to each initiative — because the person accountable for the outcome should be decided before the money is spent, not after.
Across the organizations we’ve run this with, the pattern repeats: leadership walks in with a strong technology case and a thin business case, and walks out surprised by how few of their planned initiatives actually clear the second question. That’s not a failure of their technology teams. It’s what happens when nobody asked the question earlier.
If your next AI budget cycle is coming up and you’re not certain which initiatives will move your competitive position versus which will just keep the lights on, that’s worth finding out before the money is committed, not after.
Talk to the Parkar team about running an AI Readiness Diagnostic ahead of your next budget cycle.